# Luzhou Credit Pharmaceutical Co., Ltd. – FDA Inspection, Jul 2, 2015

Source: https://www.keypedia.com/records/fda_inspections/luzhou-credit-pharmaceutical-co-ltd/b9fa5ea2-f9e8-42a1-9f6d-9e94a5625825
Source feed: FDA_Inspections

> FDA inspection 936413 of Luzhou Credit Pharmaceutical Co., Ltd., July 02, 2015. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 936413
- Company Name: Luzhou Credit Pharmaceutical Co., Ltd.
- Inspection Date: 2015-07-02
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1110329 - 2019-10-18](https://www.keypedia.com/records/fda_inspections/luzhou-credit-pharmaceutical-co-ltd/3f08a59e-66e3-4382-9193-342d91397764)
- FDA Inspection 791797 - 2012-06-21
- FDA Inspection 684993 - 2010-08-06

Company: https://www.keypedia.com/companies/luzhou-credit-pharmaceutical-co-ltd/265ddd60-155d-4fd5-80c5-5d0ce83c3f59

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c